In recent years, “One Health” has been extremely hot, and the pursuit of healthy by people goes beyond all time in the past. Following the continuous upgrading of people’s consumption structure, the wide adoption of two-child policy, and the arrival of the aging society, immense demand will emerge in a concentrated manner in time to come. The release of “Health China 2030” plan means “Health China” has formally become a “national strategy”, and the government will continue to increase its investment in health care in the future.
Besides the favorable policy environment, how about the market performance of one health industry in China? As estimated, in 2020, the market of one health will totaled RMB 10 trillion. However, compared with the U.S., Japan, and even some developing countries, it is still in its infancy. Statistics show that the health industry of the United States account for more than 15% of its GDP, and that of such countries as Canada and Japan, above 10%. In China, it is only 4-5%.
On September 8th, Ipsos was invited to the Second Global Preventive Medical Union Convention, when Ipsos Connect China Managing Director Xiaohong Wang released “Chinese Adult Health Management White Paper 2017” and shared related information.
It is noteworthy that according to the “White Paper”, more than 70% of consumers concern themselves more with health than in the past; preventive medical has become the latest trend, not only of awareness, but also of behavior; sleeping problems are more common and affect people’s health; and over 60% of consumers say they are at loss in front of all sorts of health care products.
Through online survey and expert interviews, the White Paper tries to figure out the health status and daily recuperation plan of Chinese adults and probes into their health-related attitude and behavior from a completely new perspective. It also discusses that given such a good time, how the health industry could innovate and seek healthy development opportunities.